Exelixis Inc. buy Royal Bank of Canada
Start price
14.05.25
/
50%
€39.53
Target price
14.05.26
€35.75
Performance (%)
-6.45%
Price
16.02.26
€36.98
Summary
This prediction is currently active. With a performance of -6.45%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 14.05.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Exelixis Inc. | 0.244% | 0.244% |
| iShares Core DAX® | -0,82 % | -2,03 % |
| iShares Nasdaq 100 | -1,74 % | -5,35 % |
| iShares Nikkei 225® | 1,21 % | 6,38 % |
| iShares S&P 500 | -1,17 % | -3,46 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Exelixis Inc. diskutieren
Exelixis, Inc. (NASDAQ: EXEL) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $40.00 price target on the stock.
Ratings data for EXEL provided by MarketBeat